Star Health and Allied

₹526.1 -10.3 | 1.9%

WEBSITE BSE:543412 NSE : STARHEALTH 13 May, 10:26

Market Cap ₹30755 Cr.

Stock P/E 36.4

P/B 4.9

Current Price ₹526.1

Book Value ₹ 108.5

Face Value 10

52W High ₹675

Dividend Yield 0%

52W Low ₹ 477

Edit Ratio

Star Health and Allied Research see more...

Overview Inc. Year: 2005Industry: Insurance

Star Health and Allied Insurance Company Limited presents medical insurance products. It offers retail health products to various consumer segments, consisting of individuals, families, college students, and senior citizens, as well as persons with pre-present medical situations across the middle-marketplace purchaser phase; and institution health insurance guidelines provide to employees of corporates, which includes SMEs via corporation medical insurance plans. The organization additionally affords personal accident and travel insurance. It distributes its products via individual agent, corporate agent banks, different corporate marketers, brokers and on-line channel companions comprising internet aggregators, in addition to directly to customers. As of September 30, 2021, the agency had 779 medical health insurance branches across 25 states and 5 union territories in India. Star Health and Allied Insurance Company Limited changed into integrated in 2005 and is totally based in Chennai, India.

Star Health and Allied Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Star Health and Allied Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	2528	2621	2687	2795	2867	2913	3044	3206	3294	3395
Other Income	183	181	206	208	207	220	250	258	285	296
Total Income	2711	2802	2893	3003	3074	3132	3294	3463	3579	3691
Total Expenditure	3479	2918	2605	2882	2793	2996	2909	3296	3191	3501
Operating Profit	-768	-116	288	121	282	136	384	167	388	190
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	-768	-116	288	121	282	136	384	167	388	190
Provision for Tax	-190	-34	75	28	71	34	97	42	98	47
Profit After Tax	-578	-82	213	93	210	102	288	125	290	142
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-578	-82	213	93	210	102	288	125	290	142
Adjusted Earnings Per Share	-10	-1.4	3.7	1.6	3.6	1.7	4.9	2.1	4.9	2.4

Star Health and Allied Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	511	675	1018	1514	1911	2740	3662	4684	4627	9809	11262	12939
Other Income	15	43	42	63	62	89	115	170	251	480	501	1089
Total Income	526	718	1060	1577	1974	2828	3778	4854	4877	10289	11763	14027
Total Expenditure	655	822	1207	1329	1877	2690	3548	4523	6358	11871	11057	12897
Operating Profit	-130	-105	-147	249	97	138	229	330	-1481	-1582	706	1129
Interest	1	1	1	2	3	7	2	3	3	26	35	0
Depreciation	26	10	19	17	20	23	28	29	46	43	52	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	-126	-93	-140	137	118	171	267	406	-1446	-1397	826	1129
Provision for Tax	0	0	0	0	0	1	84	143	-360	-356	208	284
Profit After Tax	-126	-93	-140	137	118	170	183	263	-1086	-1041	619	845
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-126	-93	-140	137	118	170	183	263	-1086	-1041	619	845
Adjusted Earnings Per Share	-3.8	-2.8	-3.9	3.5	2.6	3.7	4	5.4	-19.8	-18.1	10.6	14.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	15%	34%	33%	36%
Operating Profit CAGR	0%	29%	39%	0%
PAT CAGR	0%	33%	29%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-8%	NA%	NA%	NA%
ROE Average	12%	-18%	-4%	-9%
ROCE Average	15%	-22%	-4%	-9%

Star Health and Allied Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	273	190	142	360	789	960	1493	1904	3500	4604	5434
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	250	250	250	250	720	470
Other Non-Current Liabilities	345	517	751	792	1190	1683	2076	2623	5187	6229	7292
Total Current Liabilities	135	158	210	238	278	537	914	1216	1564	1961	2030
Total Liabilities	753	864	1102	1390	2257	3430	4733	5994	10501	13514	15226
Fixed Assets	51	54	46	62	77	92	85	90	80	113	101
Other Non-Current Assets	283	358	514	810	1435	2169	3043	4309	7277	12154	13971
Total Current Assets	419	453	542	518	745	1169	1605	1595	3144	1247	1154
Total Assets	753	864	1102	1390	2257	3430	4733	5994	10501	13514	15226

Star Health and Allied Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	24	40	57	80	94	229	372	750	513	1599	378
Cash Flow from Operating Activities	121	77	147	126	321	557	776	647	890	56	1276
Cash Flow from Investing Activities	-211	-70	-216	-192	-497	-663	-731	-1006	-2418	-3786	-1097
Cash Flow from Financing Activities	106	9	92	81	310	249	333	122	2613	2509	-268
Net Cash Inflow / Outflow	17	16	24	14	134	143	379	-237	1086	-1221	-89
Closing Cash & Cash Equivalent	40	57	80	94	229	372	750	513	1599	378	288

Star Health and Allied Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-3.84	0	0	0	0	0	0	0	-19.81	-18.08	10.63
CEPS(Rs)	-3.84	-2.8	-3.87	3.53	2.59	3.73	4.03	5.37	-19.81	-18.08	10.63
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	8.36	0	0	0	0	0	0	0	63.85	78.68	93.35
Core EBITDA Margin(%)	-28.19	-21.78	-18.6	12.23	1.78	1.81	3.11	3.43	-37.43	-21.02	1.82
EBIT Margin(%)	-24.57	-13.82	-13.76	9.02	6.17	6.25	7.29	8.67	-31.25	-14.24	7.34
Pre Tax Margin(%)	-24.57	-13.82	-13.76	9.02	6.17	6.25	7.29	8.67	-31.25	-14.24	7.34
PAT Margin (%)	-24.57	-13.82	-13.76	9.02	6.17	6.21	5.01	5.62	-23.47	-10.61	5.49
Cash Profit Margin (%)	-24.57	-13.82	-13.76	9.02	6.17	6.21	5.01	5.62	-23.47	-10.61	5.49
ROA(%)	-44.47	-40.32	-84.51	54.42	20.52	17.02	12.42	13.5	-36.81	-22.89	10.97
ROE(%)	-44.47	-40.32	-84.51	54.42	20.52	19.46	17.45	17.28	-40.19	-25.93	12.42
ROCE(%)	-44.47	-40.32	-84.51	54.42	20.52	17.13	20.52	22.91	-48.98	-31.04	14.83
Receivable days	0	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0	0
Payable days	0	0	0	0	0	0	0	0	0	0	0
PER(x)	0	0	0	0	0	0	0	0	0	0	48.76
Price/Book(x)	0	0	0	0	0	0	0	0	0	9.03	5.55
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	0.28	0.18	0.03	0.08	0.07	-0.02	-0.12	-0.03	-0.29	4.19	2.69
EV/Core EBITDA(x)	-1.12	-1.13	-0.23	0.46	1.29	-0.34	-1.91	-0.37	0.9	-25.95	42.95
Net Sales Growth(%)	-36.77	32.11	50.72	48.72	26.26	43.33	33.68	27.9	-1.23	112.02	14.81
EBIT Growth(%)	18.67	25.71	-50.07	197.52	-13.64	45.16	56	52.09	-455.93	3.4	159.17
PAT Growth(%)	14.86	25.71	-50.07	197.52	-13.64	44.27	7.79	43.56	-512.34	4.15	159.44
EPS Growth(%)	27.41	0	0	0	0	0	0	0	-469.12	8.72	158.81
Debt/Equity(x)	0	0	0	0	0	0	0	0	0	0.16	0.09
Current Ratio(x)	0.87	0.67	0.56	0.5	0.51	0.53	0.54	0.42	0.47	0.15	0.12
Quick Ratio(x)	0.87	0.67	0.56	0.5	0.51	0.53	0.54	0.42	0.47	0.15	0.12
Interest Cover(x)	0	0	0	0	0	0	0	0	0	0	0
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0.02	0.02

Star Health and Allied Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	58.9	58.9	58.84	58.63	58.28	58.28	58.25	58.02	57.94	57.92
FII	9.91	9.78	9.61	10.31	35.52	35.24	33.1	30.63	31	26.57
DII	27.44	27.29	27.2	1.47	1.26	1.44	3.08	6.12	6.11	11.14
Public	3.75	4.02	4.34	29.59	4.94	5.04	5.57	5.23	4.96	4.36
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	33.9	33.9	33.9	33.9	33.9	33.9	33.9	33.9	33.9	33.9
FII	5.7	5.63	5.54	5.96	20.66	20.5	19.26	17.9	18.14	15.55
DII	15.79	15.71	15.67	0.85	0.73	0.84	1.79	3.58	3.57	6.52
Public	2.16	2.32	2.5	17.11	2.87	2.93	3.24	3.06	2.9	2.55
Others	0	0	0	0	0	0	0	0	0	0
Total	57.55	57.55	57.61	57.82	58.17	58.17	58.2	58.43	58.51	58.53

Pros

Company has delivered good profit growth of 29% CAGR over last 5 years
Company has reduced debt.
Company is almost debt free.

Cons

Company has a low return on equity of -18% over the last 3 years.
Stock is trading at 4.9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.